| 000 | 01255 a2200349 4500 | ||
|---|---|---|---|
| 005 | 20250517020156.0 | ||
| 264 | 0 | _c20151021 | |
| 008 | 201510s 0 0 eng d | ||
| 022 | _a1875-5453 | ||
| 024 | 7 |
_a10.2174/1389200216666150223152958 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aLiu, Yarong | |
| 245 | 0 | 0 |
_aAdvances and challenges in the use of nanoparticles to optimize PK/PD interactions of combined anti-cancer therapies. _h[electronic resource] |
| 260 |
_bCurrent drug metabolism _c2014 |
||
| 300 |
_a818-28 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Review | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aAntineoplastic Combined Chemotherapy Protocols _xadministration & dosage |
| 650 | 0 | 4 | _aDrug Delivery Systems |
| 650 | 0 | 4 | _aDrug Design |
| 650 | 0 | 4 | _aDrug Interactions |
| 650 | 0 | 4 | _aDrug Liberation |
| 650 | 0 | 4 | _aDrug Stability |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aHydrophobic and Hydrophilic Interactions |
| 650 | 0 | 4 | _aNanoparticles |
| 650 | 0 | 4 |
_aNeoplasms _xdrug therapy |
| 700 | 1 | _aRohrs, Jennifer | |
| 700 | 1 | _aWang, Pin | |
| 773 | 0 |
_tCurrent drug metabolism _gvol. 15 _gno. 8 _gp. 818-28 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.2174/1389200216666150223152958 _zAvailable from publisher's website |
| 999 |
_c24646552 _d24646552 |
||